Potential Sources for Foreign Prices: PMPRB7

In the countries specified in the Regulations (i.e. France, Germany, Italy, Sweden, Switzerland, United Kingdom and the United States), the PMPRB has identified examples of potential sources for the benefit of patentees.  Patentees must, nevertheless, consult the appropriate sections of the Regulations and file foreign ex-factory prices in accordance with the Regulations (see s. 4(1)(f)(iii) and s. 4(9)). A non-exhaustive list of examples of potential foreign sources is set out below.

France:
Vidal
21, rue Camille-Desmoulins
Issy-Les-Moulineaux 
www.vidalfrance.com

Germany:
Lauer-Taxe
Lauer-Fischer GmbH
25 Maria Trost, Koblenz 
www.lauer-fischer.de

Italy:
L'informatore Farmaceutico
Codifa
EDRA SpA
https://www.codifa.it/

Sweden:
Dental and Pharmaceutical Benefits Agency (TLV)
20 Fleminggatan, Stockholm
www.tlv.se

Switzerland:
Federal Office of Public Health (BAG)
157 Schwarzenburgstrasse, Bern
www.spezialitätenliste.ch

United Kingdom:
Monthly Index of Medical Specialties (MIMS)
Haymarket Medical Ltd.
174 Hammersmith Road, London
www.mims.co.uk

United States of America:
Red book – Wholesale Acquisition Cost (WAC), Direct Price (DP)
Truven Health Analytics
3 Times Square, New York, (New York)
www.truvenhealth.com

US Department of Veterans Affairs – Federal Supply Schedule (FSS) 
810 Vermont Avenue, NW
Washington, (DC)
www.va.gov/nac/Pharma/List

Where necessary, the PMPRB will seek information from the patentee regarding the source of the price submitted in order to ensure it complies with the reporting requirements.